BMC Pharmacology

Search for
Advanced search
Submit a manuscript Register Sign up for article alerts Contact us

Articles

Volume 11 (2011) - February 2011

next >
up
< previous

Research article   Open Access Highly Accessed

Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro

W Dimpfel, JA Hoffmann BMC Pharmacology 2011, 11:2 (21 February 2011)

Abstract | Full text | PDF | PubMed |  Editor’s summary

The new Parkinson`s disease drug rasagiline and its metabolite aminoindan, affect the glutamate receptor mediated signaling pathway and display dose-dependent neuroprotective activity in the rat hippocampus.